These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12570116

  • 1. Use of anti-inflammatory therapy and asthma mortality in Japan.
    Suissa S, Ernst P.
    Eur Respir J; 2003 Jan; 21(1):101-4. PubMed ID: 12570116
    [Abstract] [Full Text] [Related]

  • 2. Asthma mortality in portugal : impact of treatment with inhaled corticosteroids and leukotriene receptor antagonists.
    Nunes de Melo M, Mendes Z, Martins P, Suissa S.
    Treat Respir Med; 2006 Jan; 5(2):143-7. PubMed ID: 16512694
    [Abstract] [Full Text] [Related]

  • 3. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM, Hicks GC.
    Cochrane Database Syst Rev; 2000 Jan; (3):CD002314. PubMed ID: 10908555
    [Abstract] [Full Text] [Related]

  • 4. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D, Salvio F, Hicks G.
    Cochrane Database Syst Rev; 2004 Jan; (2):CD002314. PubMed ID: 15106175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
    Riccioni G, Bucciarelli T, Mancini B, Di Ilio E, Palumbo G, D'Orazio N.
    Clin Ter; 2007 Jan; 158(4):363-70. PubMed ID: 17953289
    [Abstract] [Full Text] [Related]

  • 7. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist.
    Stempel DA, Pinto L, Stanford RH.
    J Allergy Clin Immunol; 2002 Jul; 110(1):39-41. PubMed ID: 12110816
    [Abstract] [Full Text] [Related]

  • 8. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N, Matsui H, Matsui Y, Kawashima M, Shimada M, Higaki N, Shoji S, Wada H, Fujita A, Watanabe H, Yamaguchi N, Matsuoka R, Oki K, Takahashi H, Suzuki M, Yamazaki H, Yoshizawa M, Goto H.
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [Abstract] [Full Text] [Related]

  • 9. Leukotriene receptor antagonists versus inhaled steroids in asthma.
    Richardson CR.
    J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroid use and asthma hospitalization rates in Japan.
    Odajima Y, Kuwabara H.
    J Int Med Res; 2006 Jul; 34(2):208-14. PubMed ID: 16749417
    [Abstract] [Full Text] [Related]

  • 11. Management and treatment of pediatric asthma: update.
    Skoner DP.
    Allergy Asthma Proc; 2001 Jul; 22(2):71-4. PubMed ID: 11332294
    [Abstract] [Full Text] [Related]

  • 12. Leukotriene-receptor antagonists.
    Lipworth BJ.
    Lancet; 1999 Jan 02; 353(9146):57-62. PubMed ID: 10023966
    [Abstract] [Full Text] [Related]

  • 13. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
    Perng DW, Huang HY, Lee YC, Perng RP.
    Chest; 2004 May 02; 125(5):1693-9. PubMed ID: 15136378
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T, Matsuse H, Machida I, Kondo Y, Saeki S, Tomari S, Obase Y, Matsuo N, Shimoda T, Kohno S.
    Allergy Asthma Proc; 2005 May 02; 26(4):287-91. PubMed ID: 16270722
    [Abstract] [Full Text] [Related]

  • 15. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS.
    Drugs; 2003 May 02; 63 Suppl 2():1-20. PubMed ID: 14984077
    [Abstract] [Full Text] [Related]

  • 16. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes.
    Drazen JM, Israel E.
    Am J Respir Crit Care Med; 1998 Dec 02; 158(6):1697-8. PubMed ID: 9847254
    [No Abstract] [Full Text] [Related]

  • 17. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No.
    Wenzel SE.
    Am J Respir Crit Care Med; 1998 Dec 02; 158(6):1699-701. PubMed ID: 9847255
    [No Abstract] [Full Text] [Related]

  • 18. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
    Halpern MT, Khan ZM, Stanford RH, Spayde KM, Golubiewski M.
    J Fam Pract; 2003 May 02; 52(5):382-9. PubMed ID: 12737772
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids versus leukotriene antagonists as first-line therapy for asthma: a systematic review of current evidence.
    Ducharme FM.
    Treat Respir Med; 2004 May 02; 3(6):399-405. PubMed ID: 15658885
    [Abstract] [Full Text] [Related]

  • 20. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS, Campbell D, Barnes PJ.
    Lancet; 2001 Jun 23; 357(9273):2007-11. PubMed ID: 11438132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.